共 211 条
- [1] Rahman T(2017)Enhanced status of inflammation and endothelial activation in subjects with familial hypercholesterolaemia and their related unaffected family members: a case control study Lipids Health Dis 16 81-228
- [2] Hamzan NS(2018)Role of dual lipid-lowering therapy in coronary atherosclerosis regression: evidence from recent studies Atherosclerosis. 269 219-2437
- [3] Mokhsin A(2015)Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment Eur Heart J 36 2425-2192
- [4] Rahmat R(2015)The agenda for familial hypercholesterolemia: a scientific statement from the American Heart Association Circulation. 132 2167-307
- [5] Ibrahim ZO(2018)Preliminary data of familial hypercholesterolemia (FH) patients in Romania Atherosclerosis. 277 304-1500
- [6] Razali R(2000)Outcome of case finding among relatives of patients with known heterozygous familial hypercholesterolaemia Br Med J 321 1497-188
- [7] Gragnano F(2017)Genetic architecture of familial Hypercholesterolaemia Curr Cardiol Rep 19 44-3104
- [8] Calabro P(2020)2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk Eur Heart J 41 111-297
- [9] Wiegman A(2018)2018 ESC/ESH guidelines for the management of arterial hypertension Eur Heart J 39 3021-138
- [10] Gidding SS(2018)Nontraditional risk factors in cardiovascular disease risk assessment: updated evidence report and systematic review for the US preventive services task force JAMA. 320 281-33